Jama Pitman
Corporate Officer/Principal presso DECIPHERA PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Jama Pitman is currently working as the Chief Development Officer & Senior Vice President at Deciphera Pharmaceuticals, Inc. Prior to this, Mr. Pitman completed their undergraduate degree at the University of New Hampshire.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Jama Pitman
| Società | Posizione | Inizio |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2015 |
Formazione di Jama Pitman
| University of New Hampshire | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Jama Pitman
